• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Tuesday, November 17, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Rare De Novo RAB11B Variant Disrupts Cellular Function in Autism

by
November 17, 2026
in Health
Reading Time: 4 mins read
0
Rare De Novo RAB11B Variant Disrupts Cellular Function in Autism

Rare De Novo RAB11B Variant Disrupts Cellular Function in Autism

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

In a newly reported investigation combining computational structural analysis with in vitro cellular assays, researchers have demonstrated that a rare de novo missense variant in the RAB11B gene impairs key cellular functions associated with autism spectrum disorder. The genetic variant, designated p.Arg33His, was identified in an autistic individual from a clinical family cohort. Laboratory experiments revealed that this specific mutation causes an experimental loss-of-function effect, characterized by aberrant intracellular localization of the Rab GTPase protein and direct interference with the normal outgrowth of the primary cilium. These findings identify RAB11B as a plausible candidate risk gene for autism spectrum disorder, thereby broadening the clinical and neurodevelopmental spectrum of disorders linked to mutations in this gene.

Autism spectrum disorder is recognized globally as one of the most prevalent developmental disorders, underpinned by a strong and complex genetic architecture. The extensive clinical heterogeneity and genetic diversity associated with the condition have increasingly driven large-scale genomic screening initiatives over recent years. The current investigation emerged directly from earlier genomic work conducted by the research group, in which investigators performed comprehensive genetic assessments across a monocentric family-based cohort. That patient population included 116 families and a total of 144 autistic children. Within this cohort, genomic sequencing identified a single autistic individual carrying a rare de novo missense variant in the Rab GTPase gene RAB11B, which computational prediction tools originally flagged as damaging to protein function.

Biomedical interest in RAB11B has mounted rapidly after independent studies linked the gene to a rare genetic condition characterized by severe intellectual disability, cataloged in medical genetics databases under MIM entry 617807. Prompted by this severe neurodevelopmental phenotype and the emerging candidate status of the gene, the investigators sought to functionally evaluate whether the variant detected in their autism cohort genuinely disrupts normal cellular biology. To establish an informative comparative baseline, the research team examined the cohort-derived p.Arg33His variant alongside two other missense variants identified in existing scientific literature, specifically p.Arg72Cys and p.Asp157Asn. While both of these published literature variants had similarly been computationally predicted to be pathogenic, neither variant had previously been evaluated through laboratory-based functional assays.

The investigative team initiated their experimental workflow with an in silico structural assessment to model the biophysical consequences of each amino acid substitution on the RAB11B protein. Using established molecular three-dimensional modeling software, the researchers simulated the structural impact of all three missense mutations across both the active and inactive functional states of the GTPase. The computational simulations for the cohort-derived p.Arg33His variant provided structural evidence that further supported its predicted pathogenicity. In contrast, the three-dimensional simulations for the two variants retrieved from the literature, p.Arg72Cys and p.Asp157Asn, yielded inconclusive results, underscoring the ambiguity that frequently arises when relying solely on predictive computational modeling to assess genetic alterations.

To resolve the uncertainties left by computational simulations, the investigators executed a series of in vitro biological experiments utilizing overexpressed mutant recombinant proteins. Through precise immunofluorescence assays, the researchers closely monitored the intracellular localization of each recombinant protein within cultured cells. Furthermore, the functional assays evaluated how the presence of each mutant protein influenced cellular behavior during the outgrowth of the primary cilium, an essential cellular organelle. To determine whether observed experimental differences were statistically meaningful, the research team applied one-way analysis of variance tests, followed by Tukey multiple comparisons tests to establish rigorous statistical significance across all comparisons.

The laboratory immunofluorescence assays provided empirical validation for the computational predictions, demonstrating a definitive loss-of-function effect restricted exclusively to the de novo p.Arg33His variant discovered in the autistic child. When expressed in cellular models, this particular mutated Rab protein failed to distribute to its correct intracellular compartment, resulting in abnormal cellular localization. Additionally, the presence of the p.Arg33His protein directly hindered the physical outgrowth of the primary cilium. By contrast, the two literature-derived variants, p.Arg72Cys and p.Asp157Asn, did not trigger these cellular defects in the experimental assays, establishing that predicted pathogenicity in computational models does not invariably translate into measurable cellular dysfunction.

Based on these findings, the study highlights the critical necessity of conducting experimental functional characterization to validate computational predictions of variant pathogenicity. The authors noted that while algorithms provide valuable preliminary screening data, empirical testing remains essential to distinguish benign alterations from true functional disruptions. By experimentally demonstrating that the de novo p.Arg33His variant impairs Rab protein localization and ciliary development, the research team established RAB11B as a viable candidate risk gene in autism spectrum disorder. Consequently, this work broadens the recognized neurodevelopmental spectrum associated with RAB11B-related disorders beyond severe intellectual disability, opening new avenues for understanding the shared genetic and molecular foundations of neurodevelopmental conditions.

Subject of Research: Functional characterization of rare RAB11B missense variants in autism spectrum disorder

Article Title: Investigating the role of rare missense variants in RAB11B in autism spectrum disorder

Article References: Viggiano, M., Sandoni, L., Ceroni, F., Visconti, P., Posar, A., Scaduto, M. C., Salgado, J. R., Vaisfeld, A., Maestrini, E., & Bacchelli, E. (2026). Investigating the role of rare missense variants in RAB11B in autism spectrum disorder. Journal of Neurodevelopmental Disorders. https://doi.org/10.1186/s11689-026-09729-6

Image Credits: AI Generated

DOI: 10.1186/s11689-026-09729-6

Keywords: RAB11B, autism spectrum disorder, missense variants, de novo mutation, Rab GTPase, primary cilium outgrowth, cellular localization, loss-of-function, p.Arg33His, p.Arg72Cys, p.Asp157Asn, molecular 3D modeling, immunofluorescence assays, severe intellectual disability, MIM 617807, recombinant proteins, neurodevelopmental disorders, one-way ANOVA

News Source: Ophelia Keating. (November 17, 2026). Rare De Novo RAB11B Variant Disrupts Cellular Function in Autism. Scienmag.

Tags: autism spectrum disordercellular localizationde novo mutationimmunofluorescence assaysloss-of-functionMIM 617807missense variantsmolecular 3D modelingneurodevelopmental disordersone-way ANOVAp.Arg33Hisp.Arg72Cysp.Asp157Asnprimary cilium outgrowthRab GTPaseRAB11Brecombinant proteinssevere intellectual disability
Share12Tweet7Share2ShareShareShare1

Related Posts

Rapid eGFR Decline Is Associated With Increased Mortality in Compensated Cirrhosis

Rapid eGFR Decline Is Associated With Increased Mortality in Compensated Cirrhosis

November 17, 2026
Agentic AI Framework Balances College Basketball Athlete Development With Injury Risk

Agentic AI Framework Balances College Basketball Athlete Development With Injury Risk

November 17, 2026

Over Thirty-Eight Percent of Very Elderly Atrial Fibrillation Patients Miss Anticoagulants

November 17, 2026

Research Collection Evaluates Diagnostic and Rehabilitation Strategies in Equine and Canine Athletes

November 17, 2026

POPULAR NEWS

  • City of Hope, Adagene Launch Trial Testing Combination Immunotherapy for Colorectal Cancer

    City of Hope, Adagene Launch Trial Testing Combination Immunotherapy for Colorectal Cancer

    29 shares
    Share 12 Tweet 7
  • Repetitive Mild Brain Injury Triggers Chronic Cerebrovascular Inflammation and Glymphatic Suppression

    29 shares
    Share 12 Tweet 7
  • Durable Remission in Advanced Squamous-Cell Lung Cancer Following Sodium Selenite Treatment

    29 shares
    Share 12 Tweet 7
  • Circulating tRNA Fragments Distinguish Endometriosis Patients in Preliminary Pilot Study

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Rapid eGFR Decline Is Associated With Increased Mortality in Compensated Cirrhosis

Agentic AI Framework Balances College Basketball Athlete Development With Injury Risk

Dynamic Model Captures Transient Gas Behavior in Infrared Absorption Spectroscopy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 88 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.